FDA has approved Novo Nordisk's Wegovy, one-weekly 2.4 mg semaglutide injection for treating metabolic-associated ...

About Rezdiffra Rezdiffra is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. It is the first approved medication for the treatment of MASH in the US ...

The U.S. Food and Drug Administration approved the obesity drug Wegovy for people with the chronic liver disease known as ...

The liver, a crucial organ, faces stress from toxins and poor lifestyle choices, leading to potential dysfunction. Early ...

With significant hedge fund interest and a share price under $10, 89bio, Inc. (NASDAQ:ETNB) secures a spot on our list of the ...

Elexacaftor–tezacaftor–ivacaftor was linked to a 72% lower risk of severe liver complications in cystic fibrosis patients, ...

Prosecutors charged Blair Hamilton Hayes, 61 with causing the death of 47-year-old Emma Jean Teague this March ...

Liver failure syndromes are characterized by a dysregulated immune response leading to immune paralysis. Adrenomedullin (ADM) ...

Chicago natives Ricky and Sonya Amack have opened what they call a healthier fast food restaurant. Amack’s kitchen is located ...

A Vietnamese study of cirrhotic patients with esophageal variceal bleeding finds no significant difference in outcomes ...